These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11750399)

  • 1. Targeting Jak3 for immune suppression and allograft acceptance.
    Kirken RA
    Transplant Proc; 2001; 33(7-8):3268-70. PubMed ID: 11750399
    [No Abstract]   [Full Text] [Related]  

  • 2. PNU156804 inhibits Jak3 tyrosine kinase and rat heart allograft rejection.
    Stepkowski SM; Nagy ZS; Wang ME; Behbod F; Erwin-Cohen R; Kahan BD; Kirken RA
    Transplant Proc; 2001; 33(7-8):3272-3. PubMed ID: 11750401
    [No Abstract]   [Full Text] [Related]  

  • 3. Tyrphostin AG490 selectively inhibits activation of the JAK3/STAT5/MAPK pathway and rejection of rat heart allografts.
    Kirken RA; Erwin-Cohen R; Behbod F; Wang M; Stepkowski SM; Kahan BD
    Transplant Proc; 2001; 33(1-2):95. PubMed ID: 11266723
    [No Abstract]   [Full Text] [Related]  

  • 4. Janus kinase-3 (JAK3) inhibition: a novel immunosuppressive option for allogeneic transplantation.
    Säemann MD; Zeyda M; Stulnig TM; Böhmig GA; Wekerle T; Hörl WH; Zlabinger GJ
    Transpl Int; 2004 Oct; 17(9):481-9. PubMed ID: 15368094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
    J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK3 inhibition as a new concept for immune suppression.
    Borie DC; Si MS; Morris RE; Reitz BA; Changelian PS
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1297-303. PubMed ID: 14758768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.
    Changelian PS; Flanagan ME; Ball DJ; Kent CR; Magnuson KS; Martin WH; Rizzuti BJ; Sawyer PS; Perry BD; Brissette WH; McCurdy SP; Kudlacz EM; Conklyn MJ; Elliott EA; Koslov ER; Fisher MB; Strelevitz TJ; Yoon K; Whipple DA; Sun J; Munchhof MJ; Doty JL; Casavant JM; Blumenkopf TA; Hines M; Brown MF; Lillie BM; Subramanyam C; Shang-Poa C; Milici AJ; Beckius GE; Moyer JD; Su C; Woodworth TG; Gaweco AS; Beals CR; Littman BH; Fisher DA; Smith JF; Zagouras P; Magna HA; Saltarelli MJ; Johnson KS; Nelms LF; Des Etages SG; Hayes LS; Kawabata TT; Finco-Kent D; Baker DL; Larson M; Si MS; Paniagua R; Higgins J; Holm B; Reitz B; Zhou YJ; Morris RE; O'Shea JJ; Borie DC
    Science; 2003 Oct; 302(5646):875-8. PubMed ID: 14593182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Jak3 tyrosine kinase by PNU156804 blocks rat heart allograft rejection.
    Wang M; Kirken R; Behbod F; Erwin-Cohen R; Stepkowski SM; Kahan BD
    Transplant Proc; 2001; 33(1-2):201. PubMed ID: 11266779
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection.
    Deuse T; Velotta JB; Hoyt G; Govaert JA; Taylor V; Masuda E; Herlaar E; Park G; Carroll D; Pelletier MP; Robbins RC; Schrepfer S
    Transplantation; 2008 Mar; 85(6):885-92. PubMed ID: 18360272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants.
    Borie DC; O'Shea JJ; Changelian PS
    Trends Mol Med; 2004 Nov; 10(11):532-41. PubMed ID: 15519279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of islet allograft rejection in diabetic mice by targeting Janus Kinase 3 with 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline (JANEX-1).
    Cetkovic-Cvrlje M; Dragt AL; Uckun FM
    Arzneimittelforschung; 2003; 53(9):648-54. PubMed ID: 14558439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Janus kinase 3 in the treatment of leukemia and inflammatory diseases.
    Cetkovic-Cvrlje M; Uckun FM
    Arch Immunol Ther Exp (Warsz); 2004; 52(2):69-82. PubMed ID: 15179321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of signals 1, 2, and 3 in induction of transplantation tolerance.
    Stepkowski SM; Nagy ZS; Kahan BD; Kirken RA
    Transplant Proc; 2001; 33(7-8):3831-2. PubMed ID: 11750632
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
    J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
    Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
    Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STEALTH in transplantation tolerance.
    Hutchings A; Hubbard WJ; Thomas FT; Thomas JM
    Immunol Res; 2002; 26(1-3):143-52. PubMed ID: 12403353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates.
    Borie DC; Changelian PS; Larson MJ; Si MS; Paniagua R; Higgins JP; Holm B; Campbell A; Lau M; Zhang S; Flores MG; Rousvoal G; Hawkins J; Ball DA; Kudlacz EM; Brissette WH; Elliott EA; Reitz BA; Morris RE
    Transplantation; 2005 Apr; 79(7):791-801. PubMed ID: 15818321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of Janus kinase 3 (JAK3) inhibitors.
    Cetkovic-Cvrlje M; Tibbles HE
    Curr Pharm Des; 2004; 10(15):1767-84. PubMed ID: 15180539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is JAK3 a new drug target for immunomodulation-based therapies?
    Papageorgiou AC; Wikman LE
    Trends Pharmacol Sci; 2004 Nov; 25(11):558-62. PubMed ID: 15491777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current trends in transplantation and immunosuppressive treatment.
    Manez R
    Drug News Perspect; 2003 Jun; 16(5):332-6. PubMed ID: 12942165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.